Author:
Lipsky Benjamin A,Moran Gregory J,Napolitano Lena M,Vo Lien,Nicholson Susan,Kim Myoung
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Center for Drug Evaluation and Research, Food and Drug Administration: Guidance for industry: uncomplicated and complicated skin and skin structure infections—developing antimicrobial drugs for treatment. 1998, Washington, DC: Food and Drug Administration, US Department of Health and Human Services
2. Nichols RL: Optimal treatment of complicated skin and skin structure infections. J Antimicrob Chemother. 1999, 44 (Suppl A): 19-23.
3. The new U.S. department of health and human services food and drug administration center for drug evaluation and research definition of ABSSSI includes cases of cellulitis/erysipelas, wound infection, major cutaneous abscess, and burn infection.
www.fda.gov/downloads/Drugs/…/Guidances/ucm071185.pdf
,
4. Klein E, Smith DL, Laxminarayan R: Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect Dis. 2007, 13 (12): 1840-1846. 10.3201/eid1312.070629.
5. Zilberberg MD, Shorr AF, Micek ST, Mody SH, Kollef MH: Antimicrobial therapy escalation and hospital mortality among patients with health-care-associated pneumonia: a single-center experience. Chest. 2008, 134 (5): 963-968. 10.1378/chest.08-0842.
Cited by
48 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献